Corvia Medical

Focus: Corvia Medical is a cardiovascular-focused medical device biotech company specializing in interatrial shunt technology for heart failure treatment. Founded in 2010 and headquartered in Tewksbury, MA, the company operates in the specialized cardiovascular device space.

Cardiovascular

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Open Jobs

About Corvia Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Corvia Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

8 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

IASD

Heart Failure

N/A

Clinical Trials (1)

NCT01913613REDUCE LAP-HF TRIAL

N/A

Help build intelligence for Corvia Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused pipeline of 8 trials all centered on IASD (interatrial shunt device) for heart failure indications, offering deep specialization in a validated mechanism
Cardiovascular disease represents one of the largest unmet needs globally, providing meaningful commercial opportunity and clinical impact
Medical device space offers different career trajectory than pharma, with emphasis on clinical evidence generation and regulatory navigation

Watch Out For

Zero active job openings reported and limited hiring visibility suggest company may be in operational/clinical focus mode rather than growth hiring phase
Missing financial data (funding, revenue, cash position) prevents assessment of company stability and runway for sustained employment

Generated by Claude from Corvia Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

IASD implant

Heart Failure

N/A

Clinical Trials (1)

NCT03093961REDUCE LAP-HFREF TRIAL

N/A

IASD System II

Heart Failure With Preserved Ejection Fraction

N/A

Clinical Trials (1)

NCT04632160Extended IASD Investigation: REDUCE LAP-HF IV

N/A